Tech

Johnson & Johnson to Buy Firefly Bio for $1 Billion

TWSJ·2h ago·3 min read

Photograph via The Wall Street Journal

RSS SUMMARY · AGGREGATED FROM TWSJ

Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline.

The full story continues on The Wall Street Journal.

Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.

Read on The Wall Street Journal →

The Source

The full story continues on The Wall Street Journal.

TWSJ

U.S. Employment Trends Index Ticked Down in May

Opinion | Why the ‘Hormuz Shock’ Isn’t the ’70s All Over Again

Amazon Enters Agreement With Corning for Optical Fiber for Data Centers

The Only Thing Hotter Than the Knicks Is Their Stock Price

On this beat

Mainframe modernization is about trust, not migration

​The Hidden Intake Gap: Why ABA Referral Conversion Fails Before The First Visit

Here are the IMAX theaters that can play ‘The Odyssey’ in true 70mm

Here’s Everything Coming To Destiny 2’s Final June 9 Update

The Hidden Intake Gap: Why ABA Referral Conversion Fails Before The First Visit